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Abstract
Introduction Web surveys are often used for utility valuation. Typically, custom utility valuation tools that have not undergone psychometric evaluation are used.
Objectives This study aimed to determine the psychometric properties of a metastatic epidural spinal cord compression
(MESCC) module run on a customizable open-source, internet-based, self-directed utility valuation platform (Self-directed
Online Assessment of Preferences [SOAP]).
Methods Individuals accompanying patients to the emergency department waiting room in Ottawa, Canada, were recruited.
Participants made SOAP MESCC health state valuations in the waiting room and 48 h later at home. Validity, agreement
reliability, and responsiveness were measured by logical consistency of responses, smallest detectable change, the interclass
correlation coefficient, and Guyatt’s responsiveness index, respectively.
Results Of 285 participants who completed utility valuations, only 113 (39.6%) completed the re-test. Of these 113 participants, 92 (81.4%) provided valid responses on the first test and 75 (66.4%) provided valid responses on the test and re-test.
Agreement for all groups of health states was adequate, since their smallest detectable change was less than the minimal
clinically important difference. The mean interclass correlation coefficients for all health states were > 0.8, indicating at least
substantial reliability. Guyatt’s responsiveness indices all exceeded 0.80, indicating a high level of responsiveness.
Conclusions To our knowledge, this is the first validated open-source, web-based, self-directed utility valuation module.
We have demonstrated the SOAP MESCC module is valid, reproducible, and responsive for obtaining ex ante utilities. Considering the successful psychometric validation of the SOAP MESCC module, other investigators can consider developing
modules for other diseases where direct utility valuation is needed.
Electronic supplementary material The online version of this
article (https://doi.org/10.1007/s41669-018-0092-1) contains
supplementary material, which is available to authorized users.
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Key Points for Decision Makers
The Self-directed Online Assessment of Preferences
(SOAP) tool is freely available, open-source utility-elicitation software compatible with modern web browsers,
including touch-screen mobile devices.
SOAP modules can easily be developed for other clinical
scenarios.
The SOAP MESCC module is valid, reproducible, and
responsive for ex ante utility elicitation.

1 Introduction
Quality-adjusted life-years (QALYs) are used to concurrently quantify morbidity and mortality within a single
parameter [1]. For this reason, QALYs can facilitate the
discussion of risks and benefits during patient counselling regarding treatment options [2]. To help make funding
decisions, policy makers may also combine QALYs with
cost estimates to calculate the incremental cost-effectiveness ratio [3]. QALYs are calculated using “utilities,” or
health-related quality-of-life (HRQoL) weights, which are
obtained by direct valuation or from generic health status
measures [4].
The choice of utility valuation approach is driven by
available data. Direct valuation is the classical approach
in which individuals rate hypothetical health state descriptions using the time trade-off or standard gamble procedures [5]. These procedures can be used to measure
utilities for very specific and uncommon health states.
However, it can be cumbersome to develop valid health
state descriptions for particular diseases. Alternatively,
techniques have been developed to convert generic health
status measures (e.g. EuroQol-5 Dimensions [EQ-5D],
Short Form-6 Dimensions [SF-6D], or Health Utilities
Index 3) to utilities [1]. Conversion of generic health state
measures is advantageous because custom health state
descriptions are not required. However, utilities can only
be obtained for health states actually observed in a cohort
of patients involved in the generic health survey.
Unfortunately, generic health scores have not been collected for many diseases, meaning direct valuation is necessary for measuring utilities. Best practices in economic
evaluation are to recruit a sample of healthy individuals
from the general population for utility valuation [6, 7].
Traditionally, general population utility valuation has been
conducted using face-to-face interviews, phone interviews,
or postal surveys [8]. These forms of survey administration are time intensive and costly, so web-based surveys
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are increasingly being used [9–22]. Typically, these studies are conducted using proprietary software, which limits application to other disease contexts. Furthermore, the
psychometric properties of these propriety software programs have not been assessed [23].
It is important to determine whether web-based utility
valuation has acceptable psychometric properties. If this
mode of administration has acceptable psychometric properties, rather than building custom software for new utility
valuation studies, it would be beneficial and efficient for
investigators to be able to build disease-specific modules
on a common platform that has been used to develop modules with acceptable psychometric properties. To meet this
need, we developed a new open-source (non-proprietary),
web-based, self-directed utility valuation platform useable on major computer systems (including touch-screen
devices) called the Self-directed Online Assessment of
Preferences (SOAP) (Appendix 1 and 2 in the Electronic
Supplementary Material [ESM]). SOAP was designed with
flexibility in mind and can accept new health state descriptions (modules) with minimal programming.
We decided to first create a SOAP module for metastatic
epidural spinal cord compression (MESCC), a condition for
which HRQoL data are limited. MESCC can be treated with
surgery or radiotherapy, but few high-quality studies compare these interventions using generic health status measures
for patients. However, surgery and radiotherapy outcomes
could be compared using utilities obtained by direct valuation of hypothetical probe health state descriptions. The
European Organisation for Research and Treatment of Cancer (EORTC) MESCC working group has developed an
HRQoL questionnaire for MESCC [24]. Items from this
questionnaire could be used to generate health state descriptions for a SOAP module.
The objective of this study was to determine whether the
SOAP platform can be used to develop a valid, reproducible,
and responsive module for MESCC. For this first application of the SOAP platform, we developed a MESCC module
based on the work of the EORTC and measured psychometric properties in a general population sample.

2 Methods
2.1 Self‑directed Online Assessment of Preferences
(SOAP) Platform
Electronic utility valuation protocols are distinguished by
the form of health state descriptions, assessment approach,
navigation rules, and auxiliary functions [25]. A detailed
description of these elements for the SOAP MESCC module
are provided in Appendix 1 and 2 in the ESM.
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2.2 Metastatic Epidural Spinal Cord Compression
(MESCC) Module
EORTC phase I development of a MESCC questionnaire
in Canada found that patients and healthcare providers felt
that ambulation, urinary continence, pain, and independence were important HRQoL issues for MESCC. Since
phase I development was restricted to HRQoL and did not
specifically consider treatment effects and adverse events,
we reviewed prospective studies on MESCC to identify reported outcomes and adverse events [26–29]. The
EORTC items captured all treatment outcomes identified
in our review. However, the review identified a large and
disparate set of adverse effects. To develop a manageable
decision analytic model, all adverse effects were grouped
as an “other symptoms” attribute.
A tabular (point-form) presentation of health states
was chosen as it is preferred by participants, is believed to
decrease cognitive burden compared with the narrative format, and produces similar results to the narrative format [30,
31]. Therefore, we presented health states as a point-form
list of five dysfunctional attributes: non-ambulatory (N),
incontinent of urine (I), pain (P), dependent (D), and “other
symptoms” (S). To reduce the number of potential health
states, EORTC items were collapsed to indicate the presence
(+) or absence (−) of the dysfunctional attribute, producing
32 discrete health states (Appendix 3 in the ESM).
When possible, the phrasing for presence or absence of
dysfunctional attributes was created using the same EORTC
items identified in the MESCC module development process (Table 1). Items were rephrased to the second person

and restructured as declarative sentences. Items describing
feelings or worries were not utilized as we wanted to make
the health states descriptions as objective as possible. The
rationale for the specific attribute formulation was as follows:
1. Dependence (D). The two items identified by the
MESCC working group were combined into one attribute to highlight the implications of loss of independence.
The qualifiers “do” and “do not” were added to indicate
complete function and dysfunction.
2. Lack of ambulation (N). The MESCC working group
developed a new item that was used as the functional
level. Again, two items were combined to highlight the
implications of loss of mobility.
3. Incontinence of urine (I). The item identified by the
MESCC working group with a qualifier was used as the
functional level. An item from the EORTC bladder cancer module (BLM44) was used to highlight the implications of loss of bladder control.
4. Pain (P). As MESCC can only occur in the cervical spine
to the thoracolumbar junction, pain was not differentiated
by the terms “upper” and “lower” back as was identified by the MESCC working group. As most patients
with spine metastasis will have some element of pain, the
functional state had patients requiring pain medications.
Use of pain medication served as a qualifier and was
taken from the EORTC bone metastasis module (BM38).
5. Other symptoms (S). Again, to maintain efficiency, all
adverse effects were characterized by several common
adverse symptoms. These items were all taken from the
core EORTC questionnaire.

Table 1  Health state attributes
Attributes

Symbolsa Items

EORTC codesb

Dependence

D−

C05, BM49

D+
Lack of ambulation

N−
N+

Incontinence of urine I−
I+
Pain
Other symptoms

P−
P+
S−
S+

You do not need help with eating, dressing, washing yourself or using the toilet. You
are not dependent on others
You need help with eating, dressing, washing yourself or using the toilet. You are
dependent on others
You walk without assistance
You have lost mobility because of weakness in your legs. You need to stay in bed or a
chair (or wheelchair) during the day
You have no trouble controlling your bladder
You need to insert a tube in your bladder or you need to wear a diaper full time, to
control your bladder
You have back pain relieved by pain medications
You have back pain not relieved by pain medications
You have no other uncomfortable symptoms
You have one or more of: nausea, vomiting, shortness of breath, lack of appetite, diarrhea

EORTCEuropean Organisation for Research and Treatment of Cancer, NA not applicable
a

  + indicates the presence of a dysfunctional attribute, − indicates an absence

b

Codes refer to identifiers in the EORTC item bank

C05, BM49
NA
BM48, BN48, C04
BN50
BN50, BLM44
BM31, BM38
BM31, BM38
NA
C14, C15, C08, C17
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Valuations were obtained using the standard gamble
method using a ping-pong search algorithm. In the standard
gamble, success is typically framed as “perfect” health for
an undetermined period of time. In this context, this can be
inferred to be the absence of any dysfunctions. Therefore,
the fully functional health state (D-, N-, I-, P-, S-) was chosen as the success anchor. To eliminate confusion around life
expectancy, all scenarios were framed as having a certain
life expectancy of 5 years; that is, for both the probe health
scenario and success health scenario, participants were told
their life expectancy would certainly be 5 years. This was
the maximum survival reported in a randomized controlled
trial on treatments for MESCC [27]. Probe health states were
presented in a random order.
The MESCC module was pilot tested in a sample of 40
participants to assess acceptability and ease of use. Participants were asked to rate the SOAP MESCC module using a
five-point Likert rating for the statement “[t]his website is
easy to use”, and 92.5% of participants strongly agreed or
agreed with the statement.

2.3 Subjects
To be compliant with best practice in economic evaluation,
we sought to conduct a direct utility valuation study with
a sample of the general population who have not experienced MESCC using the SOAP MESCC module (ex ante
valuation) [6]. Prior to this general population direct valuation study, psychometric properties of the SOAP MESCC
module had to be evaluated. To approximate a general
population sample for this psychometric validation study,
participants were recruited from the emergency department waiting rooms at The Ottawa Hospital, an academic
hospital in Ottawa, Ontario, Canada. Only patients’ family
members or friends (i.e. individuals accompanying patients)
aged ≥ 18 years were eligible to participate. Participants
were required to be able to read English and have access
to the internet outside of the hospital. A minimum sample
size of 50 participants has been recommended in published
guidelines for reliability and responsiveness evaluations.
[23]. To ensure robust results, we set the sample size for
this study at 75.

2.4 Survey Procedures
Participants completed the first survey in the emergency
department using a touch-screen device. Investigators did
not assist participants in navigating or completing the survey. Each participant valued the health state D + N + I + P+
S + , one randomly selected singly dysfunctional health state,
and another triply dysfunctional health state. Dysfunctional
elements were nested to ensure a logical ordering of utilities
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for the three health states. For example, if the singly dysfunctional health state was D-N-I + P-S-, the triply dysfunctional health state could include incontinence and two of
dependence, lack of ambulation, pain, or other symptoms.
Investigators contacted participants via email and/or
phone 2 days after the initial survey with information to
access the retest. Participants completed the second survey
using their personal device. For the retest, participants were
presented with the same probe health states they completed
in the emergency room, but states were presented in a new
random order.

2.5 Statistical Analysis
“Validity” refers to whether a tool under investigation measures what it is supposed to measure [32]. Specifically, “construct validity” concerns whether results obtained using the
tool under investigation are consistent with a priori hypotheses [32]. We hypothesized that utility valuations should
follow the logical ordering of health states, with utility
valuations following the relationship: singly ≥ triply ≥ fully
dysfunctional. We considered singly = triply = fully a valid
response because we could not exclude the possibility of a
ceiling effect with one dysfunction. Participant responses
were deemed “valid” if their utilities followed this order.
The proportion of participants providing valid responses on
the test and retest was computed.
“Reproducibility” concerns the stability of participants’
responses on repeated testing and can be characterized by
agreement and reliability [32]. “Agreement” quantifies the
absolute differences in participants’ repeated responses. We
assessed agreement using the smallest detectable change
[23]. We classified agreement as adequate if the smallest detectable change was less than the minimal clinically
important difference (MCID) [23]. By anchoring to Eastern
Cancer Oncology Group functional levels, an MCID of 0.05
for cancer utilities obtained by the three-level EQ-5D (EQ5D-3L) has been proposed [33]. This MCID has also been
used for direct utility valuation by the standard gamble and
time trade-off of EQ-5D-3L health states [34]. The precision
of the standard gamble algorithm used in our study was also
0.05. Therefore, we used an MCID of 0.05 in this study. Systematic differences between the test and retest sessions were
quantified using the smallest detectable change calculation.
“Reliability” concerns the fraction of pooled study variance
across the repeated tests attributable to differences between
participants (participant variance) and individual test–retest
variability (noise) [32]. If responses are stable, the ratio of
noise to participant variance should be small, and the ratio
of participant variance to variance for the pooled results
from test and retest should be high. Reliability accounting
for systematic differences between the test and retest, stratified for the number of dysfunctions in the health state, was
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quantified using the intraclass correlation coefficient (ICC)
using the following categories: < 0.21, slight reliability;
0.21–0.40, fair reliability; 0.41–0.60, moderate reliability;
0.61–0.80, substantial reliability; > 0.80, almost perfect reliability [35]. An ICC ≥ 0.70 was considered adequate [23].
“Responsiveness” reflects the ability of a tool to detect
clinically important changes and can be quantified using
Guyatt’s responsiveness index [36]. This index is proportional to the ratio of the MCID to the root mean squared
error of the difference between the test and retest value. If
test–retest variability is small relative to the MCID, the tool
is deemed responsive because meaningful changes are of
greater magnitude than test–retest fluctuation [37]. Values
of 0.20, 0.50, and 0.80 were interpreted as small, moderate,
and large levels of responsiveness, respectively [38].
Statistical analysis was performed using the statistical programming language R [39]. The distribution of
age (Kruskal–Wallis test) and sex (Chi squared test) was
compared between participants providing valid and invalid
responses on the test and retest. We considered logically
ordered responses to be valid, that is decreasing utilities
assigned to the singly, triply, and fully dysfunctional states.
Age was assessed using a one-way analysis of variance
(ANOVA). Sex was assessed using the Chi squared test.
Reproducibility, agreement, reliability, and responsiveness were only measured for participants providing valid
responses on both the test and the retest. Since the SOAP
tool is intended for measuring average utilities from the
general public, average measures (rather than individual
measures) of smallest detectable change, ICCs, and Guyatt’s
responsiveness indices were calculated [40].

3 Results
Of 285 participants who completed utility valuations in
the emergency department, only 113 (39.6%) completed
the retest. Of these 113 participants, 92 (81.4%) provided
valid responses on the first test, and 75 (66.4%) provided
valid responses on the test and retest (Table 2). The response
validity pattern was not associated with age (p = 0.2336) or
sex (p = 0.971) (Table 2). Only data from the participants
providing valid responses on both the test and the retest were
Table 2  Characteristics of
participants stratified by
response pattern

Table 3  Agreement, reliability, and responsiveness measurements
Number of
Smallest
dysfunctions detectable
change

ICC (95% CI)

Guyatt’s
responsiveness
index

Single
Triple
Full

0.879 (0.808–0.923)
0.898 (0.838–0.935)
0.826 (0.724–0.890)

1.45
1.47
1.24

0.036
0.035
0.042

CI confidence interval, ICC intraclass correlation coefficient

used for reproducibility and responsiveness analysis. Seven
respondents skipped at least one scenario during the test
and were classified as providing invalid responses. Only one
respondent skipped one question during the retest, and the
responses were also classified as invalid.
Agreement for all groups of health states was adequate
since their smallest detectable change was less than the
MCID of 0.05 (Table 3). Mean ICCs were all > 0.8, indicating substantial reliability, and all ICCs were significantly
greater than the pre-specified threshold of 0.7 (Table 3).
Guyatt’s responsiveness indices all exceeded 0.80, indicating
large responsiveness for the utility evaluation (Table 3) [38].

4 Discussion
Utility valuation studies are traditionally conducted using
face-to-face interviews, phone interviews, or postal surveys.
These modes of administration have undergone psychometric validation. Web surveys are increasingly used for utility
valuation and usually use custom and proprietary valuation
tools that have not been psychometrically validated. It would
be beneficial and efficient for investigators to be able to build
disease-specific modules on a common platform that has
been used to develop modules with acceptable psychometric
properties.
We developed a new platform called the SOAP (Appendix 1 and 2 in the ESM). For the first application of this
platform, we developed a module for MESCC health states.
The SOAP platform met published benchmarks for reproducibility (both agreement and reliability) and responsiveness for utility measurement. This study demonstrated that

Characteristics

Valid → valid

Valid → invalid

Invalid → valid

Invalid → invalid

Total
Age in years
Sex
Female
Male

75 (66.4)
53.0 [33.5, 61.0]

17 (15.0)
43.0 [33.0, 48.0]

17 (15.0)
51.0 [38.0, 62.0]

4 (3.6)
43.0 [33.25, 52.0]

47 (62.7)
28 (37.3)

11 (64.7)
6 (35.3)

11 (58.8)
6 (41.2)

3 (75.0)
1 (25.0)

Data are presented as N (%), except for age, which is presented as median [interquartile range]

p value
0.2336
0.971
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the SOAP platform can be used to develop modules with
acceptable psychometric properties.
In total, 81.4% of participants provided valid responses
on the first test, and 66.4% of participants provided valid
responses on both the test and the retest. These results
should be considered in the context of other ex ante valuation studies reported in the literature. We classified a participant’s responses as valid if their utility valuations decreased
with increasing dysfunctional attributes in the health state.
For example, if a participant valued the fully dysfunctional
health state higher than the single dysfunctional health state,
their responses were classified as invalid. This definition of
validity is termed “logical consistency” and has been used in
traditional general population ex ante utility valuation studies of EQ-5D-3L health states.
Logical consistency rates for face-to face valuations have
been reported for the UK and Netherlands [41, 42]. In the
UK study, 12 pairs of health states per participant could be
evaluated for logical consistency. The median rate of logical consistency, per participant, ranged from 83.8 to 91.7%.
In the Dutch study, 87.6% of participants provided at least
one pair of logically inconsistent valuations. Postal surveys
conducted in the USA and New Zealand reported at least one
logically inconsistent pairing in 88 and 79% of participants,
respectively [43, 44]. With 81.4% of participants providing a valid response (28.6% providing a logically inconsistent response), the logical consistency rate for the SOAP
MESCC module was similar to that of traditional population
studies. Logical consistency has also been assessed for other
self-administered general population ex ante utility valuation
studies of EQ-5D-3L health states over the internet [19, 45,
46]. Each study reported a logical consistency rate < 70%.
Compared with the SOAP MESCC module, the faceto-face, postal, and web-based EQ-5D-3L utility valuation
studies required greater cognitive effort because participants
rated more health states (between five and ten) that were
also more complex (five attributes and three levels of dysfunction). Furthermore, these studies did not provide error
checking, whereas the SOAP MESCC module notified participants of a logical error if they rejected a lottery with
100% of success. Considering these differences, a logical
consistency rate of 81.4% on the first test with the SOAP
MESCC module is consistent with the literature.
Valuing MESCC health states using the classical standard
gamble is problematic for two reasons. First, the classical
standard gamble uses perfect health as a top anchor, which
is an unrealistic outcome for metastatic cancer. Second, the
classical standard gamble considers timeless (i.e. perpetual)
health states, which is incongruent with the metastatic cancer disease process. To make the standard gamble more realistic, we characterised perfect health as the absence of dysfunctions and restricted all health states (including the top
anchor) to a survival period of 5 years. These modifications
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may affect the interpretation of our results relative to classic
utility assessment.
Utilities are typically estimated for specific health states
and are used to weight the time in such health states. Consequently, a utility value for a specific state is typically
considered “timeless,” that is, utilities are usually assumed
not to change with time spent in a health state [47]. As
a reflection of this, the duration of time spent in a probe
health state is not specified in the classical standard gamble
[5]. For MESCC health states, we were concerned that the
most severe health states would connote poor survival and
therefore confound the measurement of HRQoL using the
standard gamble with quantity of life. To alleviate this difficulty, we explicitly stated a 5-year duration for each health
state, which was the longest survival observed in a randomized controlled trial of treatments for MESCC [27]. This
approach has also been used in other utility valuation studies for cancer health states [48]. This modification to health
state descriptions should not affect results because the standard gamble (and all other utility-elicitation methods) relies
on the “utility independence” assumption [49]. Under this
assumption, if a health state has a utility of x , the utility of
this health state for 5 years should still be x . Unfortunately, a
systematic review concluded that individuals tend not to satisfy the utility independence assumption with no consistent
pattern of violation [50]. We are unaware of any algorithm
to convert utilities for fixed period of time to “timeless” utilities. Consequently, the utilities measured in this study may
not be directly comparable to utilities obtained using the
classical standard gamble.
A strength of our study is that we built on the work conducted by the EORTC MESCC working group to ensure
the attributes in the MESCC module were appropriate and
representative of the MESCC disease process. A limitation
of our study is that we did not assess criterion validity by
comparing utilities obtained by SOAP MESCC and a “gold
standard” [32]. This could be done by having patients with
MESCC value their own health using the SOAP MESCC
module and comparing these utility valuations with those
derived from a generic health questionnaire. We did not have
the resources to conduct such a study. Furthermore, measures of logical validity, reproducibility, and responsiveness
are more relevant than MESCC criterion validity to investigators considering developing modules for new diseases.
To our knowledge, this is the first validated open-source,
web-based, self-directed utility valuation module. For the
first application of the SOAP platform, we developed a module for MESCC health states. We have demonstrated the
SOAP MESCC module is valid, reproducible, and responsive for obtaining ex ante utilities. Considering the successful psychometric validation of the SOAP MESCC module,
other investigators can consider developing modules for
other diseases where direct utility valuation is needed.
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